<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To report presentation and outcome of rhino-orbital-cerebral <z:e sem="disease" ids="C0026718" disease_type="Disease or Syndrome" abbrv="">mucormycosis</z:e> (ROCM) exclusively in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Retrospective, non-comparative, interventional analysis of the medical records of 35 patients with ROCM among 22 316 patients with <z:mp ids='MP_0002055'>diabetes</z:mp> seen over the last 12 years </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: A cohort of 23 men and 12 women with a mean (SD) age of 47.3 (14.4) years (range 18-70 years) was studied </plain></SENT>
<SENT sid="3" pm="."><plain>Five patients had type 1 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, 29 had type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, and one had secondary <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Nine patients had ROCM as the first clinical manifestation of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The mean (SD) blood <z:chebi fb="105" ids="17234">glucose</z:chebi> at presentation was 20.6 (8.3) mmol/l (range 10.0 to 53.3 mmol/l) and 17 patients had <z:hpo ids='HP_0001946'>ketosis</z:hpo>/<z:hpo ids='HP_0001993'>ketoacidosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Ophthalmic symptoms and signs were pronounced: <z:hpo ids='HP_0000544'>external ophthalmoplegia</z:hpo> (89%), <z:hpo ids='HP_0000520'>proptosis</z:hpo> (83%), <z:hpo ids='HP_0000572'>visual loss</z:hpo> (80%), chemosis (74%), and eye lid <z:hpo ids='HP_0100758'>gangrene</z:hpo> (14%) </plain></SENT>
<SENT sid="7" pm="."><plain>Non-ophthalmic manifestations included <z:hpo ids='HP_0000246'>sinusitis</z:hpo> (100%), nasal discharge/ulceration (74%), infranuclear <z:e sem="disease" ids="C0271355" disease_type="Disease or Syndrome" abbrv="">VI nerve palsy</z:e> (46%), palatal <z:mp ids='MP_0001651'>necrosis</z:mp> (29%), cerebral lobe involvement (20%), and <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> (17%) </plain></SENT>
<SENT sid="8" pm="."><plain>Computed tomography/magnetic resonance imaging showed involvement of paranasal sinuses in <z:hpo ids='HP_0000001'>all</z:hpo> patients with ethmoid (86%) and maxillary (80%) sinuses being most frequently involved </plain></SENT>
<SENT sid="9" pm="."><plain>Orbital involvement was observed in 80% of patients with cavernous sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> in 11%, and internal carotid occlusion and <z:hpo ids='HP_0000238'>hydrocephalus</z:hpo> in 3% each </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were treated with <z:chebi fb="1" ids="2682">amphotericin B</z:chebi> (3-3.5 g) and 26 (74%) patients underwent appropriate surgery </plain></SENT>
<SENT sid="11" pm="."><plain>Twenty one patients (68%) survived with a mean (SD) follow up of 39.6 (34.1) months (range 10 months to 11 years) </plain></SENT>
<SENT sid="12" pm="."><plain>Factors related to poor survival included delay in diagnosis and treatment (p&lt;0.05), facial and/or eye lid <z:hpo ids='HP_0100758'>gangrene</z:hpo> (p&lt;0.05), <z:hpo ids='HP_0002301'>hemiplegia</z:hpo> (p&lt;0.05), cerebral invasion by mucorales (p&lt;0.05), and treatment with <z:chebi fb="1" ids="2682">amphotericin B</z:chebi> alone (p&lt;0.05) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: In patients with <z:mp ids='MP_0002055'>diabetes</z:mp> and ROCM, ROCM was the presenting manifestation in one fourth of the patients </plain></SENT>
<SENT sid="14" pm="."><plain>Ophthalmic and extensive cerebral involvement predominated in the clinical picture </plain></SENT>
<SENT sid="15" pm="."><plain>Delay in treatment due to late presentation and associated complications were major determinants of the survival outcome in these patients </plain></SENT>
</text></document>